| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.90B | 31.12B | 25.95B | 25.52B | 23.78B | 24.16B |
| Gross Profit | 7.74B | 6.77B | 5.28B | 4.61B | 5.37B | 5.71B |
| EBITDA | 10.06B | 9.21B | 8.00B | 7.22B | 6.14B | 3.98B |
| Net Income | 3.29B | 2.58B | 2.02B | 1.56B | 821.41M | -933.79M |
Balance Sheet | ||||||
| Total Assets | 109.93B | 108.58B | 110.46B | 100.40B | 102.47B | 100.43B |
| Cash, Cash Equivalents and Short-Term Investments | 6.30B | 7.16B | 10.85B | 8.60B | 9.61B | 6.58B |
| Total Debt | 24.96B | 27.05B | 32.14B | 27.30B | 30.76B | 34.71B |
| Total Liabilities | 46.40B | 45.99B | 49.70B | 43.03B | 47.16B | 45.46B |
| Stockholders Equity | 60.81B | 59.91B | 58.13B | 54.85B | 52.78B | 52.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.64B | -1.24B | -163.71M | 7.51B | 2.10B |
| Operating Cash Flow | 0.00 | 5.24B | 784.58M | 2.02B | 8.47B | 4.76B |
| Investing Cash Flow | 0.00 | -3.42B | -3.83B | 1.20B | -449.19M | -2.70B |
| Financing Cash Flow | 0.00 | -5.66B | 5.10B | -4.46B | -5.12B | -1.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥107.29B | 5.88 | ― | 2.93% | 20.83% | 57.13% | |
71 Outperform | ¥91.21B | 14.58 | ― | 2.19% | 4.72% | 47.55% | |
67 Neutral | ¥49.07B | 13.35 | ― | 2.93% | 26.99% | -26.97% | |
67 Neutral | ¥77.67B | 11.54 | ― | ― | 127.32% | -22.79% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥78.05B | 23.41 | 1.46% | 1.18% | 6.40% | 230.12% | |
62 Neutral | ¥70.64B | 3.41 | ― | 2.89% | -3.09% | -35.66% |